Heparin-induced Thrombocytopenia
What's New
Last Posted: Mar 10, 2023
- High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation.
Castelli Roberto, et al. Journal of thrombosis and thrombolysis 2017 0 (1) 106-113 - Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.
Irani Mehraboon, et al. Transfusion 2018 0 (3) 931-934 - Heterogeneity in neutrophil responses to immune complexes.
Duarte Madelaine, et al. Blood advances 2019 0 (19) 2778-2789 - Heparin for preventing adverse obstetrical outcomes in pregnant women with antiphospholipid syndrome, a systematic review and meta-analysis.
Guerby Paul, et al. Journal of gynecology obstetrics and human reproduction 2020 0 (2) 101974 - Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature.
Gruel Yves, et al. Thrombosis and haemostasis 2020 0 (7) 1096-1107 - Screening and diagnosis of heparin-induced thrombocytopenia in the pediatric population: A tertiary centre experience.
Chok Rozalyn, et al. Thrombosis research 2021 0 1-6 - ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia.
Karnes Jason H, et al. Blood 2022 0 (3) 274-284 - A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Nilius Henning et al. EClinicalMedicine 2022 55101745 - Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia.
Giles Jason B, et al. Blood advances 2022 5 - Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know?
Karnes Jason H et al. Pharmacogenomics 2018 Nov
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: